We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+25.81%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$241M
AUM Growth
+$50.3M
Cap. Flow
+$11.8M
Cap. Flow %
4.88%
Top 10 Hldgs %
9.37%
Holding
372
New
47
Increased
146
Reduced
160
Closed
17

Top Buys

Rank Stock Value
1
BEPC icon
Brookfield Renewable
BEPC
+$1.51M
2
WES icon
Western Midstream Partners
WES
+$926K
3
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
+$707K
4
DK icon
Delek US
DK
+$681K
5
CVI icon
CVR Energy
CVI
+$669K

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$1.61M
2
AIMT
Aimmune Therapeutics
AIMT
+$1.13M
3
AIV
Aimco
AIV
+$1.1M
4
VIV icon
Telefônica Brasil
VIV
+$1.01M
5
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$988K

Sector Composition

Rank Sector Weight
1 Healthcare 29.53%
2 Real Estate 18.96%
3 Energy 16.61%
4 Materials 11.31%
5 Utilities 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
O icon
76
Realty Income
O
$61.3B
$1.43M 0.59%
23,681
+2,734
+13% +$162K
STAG icon
77
STAG Industrial
STAG
$7.79B
$1.4M 0.58%
44,788
+2,209
+5% +$69K
INGR icon
78
Ingredion
INGR
$6.48B
$1.4M 0.58%
17,802
+3,131
+21% +$241K
PTR
79
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$1.37M 0.57%
44,568
+8,938
+25% +$273K
TEO icon
80
Telecom Argentina
TEO
$5.86B
$1.35M 0.56%
206,391
+65,526
+47% +$484K
XRN
81
Chiron Real Estate Inc
XRN
$541M
$1.35M 0.56%
20,713
-886
-4% -$61K
D icon
82
Dominion Energy
D
$62.1B
$1.35M 0.56%
17,955
+2,953
+20% +$235K
CCOI icon
83
Cogent Communications
CCOI
$649M
$1.35M 0.56%
22,482
+6,929
+45% +$410K
NEM icon
84
Newmont
NEM
$96.4B
$1.31M 0.54%
21,921
+521
+2% +$32.1K
CEO
85
DELISTED
CNOOC Limited
CEO
$1.24M 0.51%
13,518
+2,709
+25% +$268K
TRP icon
86
TC Energy
TRP
$70.5B
$1.23M 0.51%
30,196
+1,957
+7% +$83.3K
OXLC
87
Oxford Lane Capital
OXLC
$854M
$1.11M 0.46%
41,091
-5,580
-12% -$138K
ECC
88
Eagle Point Credit Company
ECC
$497M
$998K 0.41%
98,910
-22,927
-19% -$208K
AGIO icon
89
Agios Pharmaceuticals
AGIO
$2.14B
$772K 0.32%
17,822
+5,424
+44% +$214K
ITCI
90
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$766K 0.32%
24,085
+8,782
+57% +$231K
SAGE
91
DELISTED
Sage Therapeutics
SAGE
$745K 0.31%
8,611
-7,531
-47% -$555K
BBDC icon
92
Barings BDC
BBDC
$885M
$740K 0.31%
80,465
+8,934
+12% +$75.9K
RDUS
93
DELISTED
Radius Health, Inc.
RDUS
$739K 0.31%
41,375
-3,106
-7% -$46.6K
IONS icon
94
Ionis Pharmaceuticals
IONS
$9.14B
$719K 0.3%
12,725
+2,712
+27% +$135K
ONC
95
BeOne Medicines Ltd
ONC
$34.3B
$690K 0.29%
2,669
-896
-25% -$247K
UTHR icon
96
United Therapeutics
UTHR
$26.1B
$645K 0.27%
4,252
-812
-16% -$107K
BMRN icon
97
BioMarin Pharmaceuticals
BMRN
$12B
$644K 0.27%
7,346
+1,817
+33% +$144K
PNNT
98
Pennant Park Investment Corp
PNNT
$221M
$635K 0.26%
137,760
+72,092
+110% +$273K
VRTX icon
99
Vertex Pharmaceuticals
VRTX
$124B
$631K 0.26%
2,668
+492
+23% +$113K
ACAD icon
100
Acadia Pharmaceuticals
ACAD
$4.45B
$624K 0.26%
11,675
-1,073
-8% -$53.3K
2 3
4
5 6

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Virtus ETF Advisers held 372 positions worth $241M, up 26% from $191M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Virtus ETF Advisers deployed $11.8M of net new capital in Q4 2020, opening 47 new positions and adding to 146 existing holdings. Its largest new stake was Harmony Biosciences: 14,899 shares worth $539K.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Amicus Therapeutics, an estimated $572K trimmed.

  • Virtus ETF Advisers's largest Q4 2020 buy was Harmony Biosciences: 14,899 shares worth $539K.
  • Virtus ETF Advisers added most to Brookfield Renewable in Q4 2020, an estimated $1.51M increase.
  • Virtus ETF Advisers's biggest Q4 2020 reduction was Amicus Therapeutics, cutting an estimated $572K.
  • Virtus ETF Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $1.61M.
  • Virtus ETF Advisers's ten largest holdings make up 9.4% of its $241M portfolio in Q4 2020.
  • Virtus ETF Advisers opened 47 new positions and closed 17 in Q4 2020.
  • Virtus ETF Advisers's portfolio value rose 26% quarter-over-quarter to $241M.

Based on Virtus ETF Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.